Compare · CDXS vs WLK
CDXS vs WLK
Side-by-side comparison of Codexis Inc. (CDXS) and Westlake Corporation (WLK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDXS and WLK operate in Major Chemicals (Industrials), so they compete in similar markets.
- WLK is the larger of the two at $10.92B, about 46.1x CDXS ($236.8M).
- Over the past year, CDXS is up 9.0% and WLK is up 12.3% - WLK leads by 3.3 points.
- WLK has been more active in the news (4 items in the past 4 weeks vs 1 for CDXS).
- WLK has more recent analyst coverage (25 ratings vs 12 for CDXS).
- Company
- Codexis Inc.
- Westlake Corporation
- Price
- $2.60+2.36%
- $85.25+0.80%
- Market cap
- $236.8M
- $10.92B
- 1M return
- +0.39%
- -12.46%
- 1Y return
- +9.01%
- +12.30%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2010
- 2004
- News (4w)
- 1
- 4
- Recent ratings
- 12
- 25
Codexis Inc.
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
Westlake Corporation
Westlake Chemical Corporation, together with its subsidiaries, manufactures and markets basic chemicals, vinyls, polymers, and building products worldwide. It operates through two segments, Vinyls and Olefins. The Vinyls segment provides specialty and commodity polyvinyl chloride (PVC), vinyl chloride monomers, ethylene dichloride, chlorine, caustic soda, chlorinated derivative, and ethylene products. This segment also manufactures and sells PVC compounds and building products fabricated from PVC, including residential siding, trim and molding, pipe and fittings for various water, sewer and industrial applications, profiles for windows and doors, decking products, films for various inflatables, wall covering tapes, roofing applications, and composite roof tiles. The Olefins segment offers polyethylene, styrene monomers, and various ethylene co-products, as well as sells propylene, crude butadiene, pyrolysis gasoline, and hydrogen products. Westlake Chemical Corporation offers its products to a range of customers, including chemical processors, plastics fabricators, small construction contractors, municipalities, and supply warehouses in various consumer and industrial markets, such as flexible and rigid packaging, automotive products, coatings, water treatment, refrigerants, and residential and commercial construction, as well as other durable and non-durable goods. The company was founded in 1986 and is headquartered in Houston, Texas. Westlake Chemical Corporation is a subsidiary of TTWF LP.
Latest CDXS
- Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
- SEC Form 10-Q filed by Codexis Inc.
- Codexis Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- Codexis Reports First Quarter 2026 Financial Results
- Codexis to share RNA manufacturing advances at TIDES USA
- SEC Form DEFA14A filed by Codexis Inc.
- SEC Form DEF 14A filed by Codexis Inc.
- Codexis to Report First Quarter 2026 Financial Results on May 7
- SEC Form 8-K filed by Codexis Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Codexis Inc.
Latest WLK
- Westlake Corporation downgraded by Citigroup with a new price target
- SEC Form 8-K filed by Westlake Corporation
- SEC Form SD filed by Westlake Corporation
- Westlake Corporation upgraded by Analyst with a new price target
- Westlake Corporation Declares Quarterly Dividend
- EVP & CFO Bender Mark Steven converted options into 13,164 shares and covered exercise/tax liability with 5,284 shares, increasing direct ownership by 28% to 35,895 units (SEC Form 4) to cover withholding tax
- SEC Form 10-Q filed by Westlake Corporation
- Westlake Corporation downgraded by Analyst with a new price target
- Westlake Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Westlake Corporation Reports First Quarter 2026 Results